These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35112375)

  • 1. Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.
    Tao X; Zhao Y; Chen L; Zeng M; Mi Y; Xu L
    Hepatology; 2022 Jul; 76(1):E13-E14. PubMed ID: 35112375
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-induced chronic active hepatitis].
    Blanc F; Monnin E; Brunin JL
    Rev Med Interne; 1987; 8(4):402-6. PubMed ID: 3423479
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic active hepatitis associated with trazodone therapy.
    Beck PL; Bridges RJ; Demetrick DJ; Kelly JK; Lee SS
    Ann Intern Med; 1993 May; 118(10):791-2. PubMed ID: 8470853
    [No Abstract]   [Full Text] [Related]  

  • 4. Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment.
    Weber S; Gerbes AL
    Am J Gastroenterol; 2021 Oct; 116(10):2151-2152. PubMed ID: 34187981
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenytoin-induced chronic hepatitis.
    Roy AK; Mahoney HC; Levine RA
    Dig Dis Sci; 1993 Apr; 38(4):740-3. PubMed ID: 8462373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the editor: A revised electronic version of RUCAM for the diagnosis of drug-induced liver injury.
    Devarbhavi H; Kurien SS
    Hepatology; 2022 Oct; 76(4):E71-E72. PubMed ID: 35451140
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the editor: RECAM for the diagnosis of DILI-Is it time to incorporate additional pharmacological criteria?
    Raschi E; Caraceni P
    Hepatology; 2022 Jul; 76(1):E25-E26. PubMed ID: 35220617
    [No Abstract]   [Full Text] [Related]  

  • 8. Ashwagandha as a cause for liver injury.
    Björnsson HK; Björnsson ES; Avula B; Khan IA; Jonasson JG; Ghabril M; Hayashi PH; Navarro V
    Liver Int; 2020 Aug; 40(8):2035-2036. PubMed ID: 32475004
    [No Abstract]   [Full Text] [Related]  

  • 9. Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial.
    Wang JB; Huang A; Wang Y; Ji D; Liang QS; Zhao J; Zhou G; Liu S; Niu M; Sun Y; Tian H; Teng GJ; Chang BX; Bi JF; Peng XX; Xin S; Xie H; Ma X; Mao YM; Liangpunsakul S; Saxena R; Aithal GP; Xiao XH; Zhao J; Zou Z
    Aliment Pharmacol Ther; 2022 May; 55(10):1297-1310. PubMed ID: 35362188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis.
    Scully LJ; Clarke D; Barr RJ
    Dig Dis Sci; 1993 Apr; 38(4):744-51. PubMed ID: 8462374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors of tigecycline-induced liver injury: A multicenter retrospective study.
    Yu Z; Zhao Y; Jin J; Zhu J; Yu L; Han G
    Int J Infect Dis; 2022 Jul; 120():59-64. PubMed ID: 35429639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic active hepatitis associated with cimetidine.
    Boyd PT; Lepre F; Dickey JD
    BMJ; 1989 Feb; 298(6669):324-5. PubMed ID: 2493922
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic and prognostic assessment of suspected drug-induced liver injury in clinical practice.
    Andrade RJ; Robles-Díaz M
    Liver Int; 2020 Jan; 40(1):6-17. PubMed ID: 31578817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the editor: Concerning the paper entitled "TC (Giloy) induced liver injury…" by Anand Kulkarni et al.
    Edamana SN; Hegde S; Vasudevan R
    Hepatol Commun; 2022 Aug; 6(8):2221-2222. PubMed ID: 35503793
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of AhR-NQO1 Signaling Pathway Protects Against Alcohol-Induced Liver Injury by Improving Redox Balance.
    Dong H; Hao L; Zhang W; Zhong W; Guo W; Yue R; Sun X; Zhou Z
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):793-811. PubMed ID: 34082111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetaminophen Hepatotoxicity: Strong Offense and Weakened Defense.
    Kaplowitz N; Than TA; Win S
    Hepatology; 2020 May; 71(5):1530-1532. PubMed ID: 32065403
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: Liver toxicity of digitalis glycosides].
    Hochrein H
    Dtsch Med Wochenschr; 1975 Apr; 100(16):913. PubMed ID: 1122858
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Halothane hepatitis.
    Anderson RD; Davis NJ
    Med J Aust; 1974 Aug; 2(6):226. PubMed ID: 4419951
    [No Abstract]   [Full Text] [Related]  

  • 19. Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians.
    Houron C; Danielou M; Mir O; Fromenty B; Perlemuter G; Voican CS
    Crit Rev Oncol Hematol; 2021 Jan; 157():103127. PubMed ID: 33161366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of human leukocyte antigen-B*13:01 with dapsone-induced liver injury.
    Devarbhavi H; Patil M; Menon M
    Br J Clin Pharmacol; 2022 Mar; 88(3):1369-1372. PubMed ID: 34427944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.